Author:
Bagante Fabio,Spolverato Gaya,Weiss Matthew,Alexandrescu Sorin,Marques Hugo P.,Aldrighetti Luca,Maithel Shishir K.,Pulitano Carlo,Bauer Todd W.,Shen Feng,Poultsides George A.,Soubrane Oliver,Martel Guillaume,Groot Koerkamp B.,Guglielmi Alfredo,Itaru Endo,Pawlik Timothy M.
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Liver Cancer Study Group of Japan. Intrahepatic cholangiocarcinoma macroscopic typing. In: Okamoto E (ed). Classification of primary liver cancer. Tokyo, Japan, Kanehara; 1997. pp 6–7.
2. Dodson RM, Weiss MJ, Cosgrove D, et al. Intrahepatic cholangiocarcinoma: management options and emerging therapies. Journal of the American College of Surgeons. 2013;217(4):736–50.
3. Amini N, Ejaz A, Spolverato G, Kim Y, Herman JM, Pawlik TM. Temporal trends in liver-directed therapy of patients with intrahepatic cholangiocarcinoma in the United States: a population-based analysis. Journal of Surgical Oncology. 2014;110(2):163–70.
4. de Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. Journal of Clinical Oncology. 2011;29(23):3140–45.
5. Hyder O, Hatzaras I, Sotiropoulos GC, et al. Recurrence after operative management of intrahepatic cholangiocarcinoma. Surgery. 2013;153(6):811–18.
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献